Propel Bio Management LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-23 2:20 pm Purchase | 2025-07-11 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Propel Bio Management LLC | 8,861,186 9.900% | 8,861,186 (New Position) | Filing |